SALIM VIRANI to Humans
This is a "connection" page, showing publications SALIM VIRANI has written about Humans.
Connection Strength
6.439
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2025 Feb 06; 27(1):30.
Score: 0.027
-
Highlights of Cardiovascular Disease Prevention Studies?Presented at the 2024 European Society of Cardiology?Congress. Curr Atheroscler Rep. 2024 Dec 02; 27(1):14.
Score: 0.026
-
Health Data Sciences and Cardiovascular Disease in Africa: Needs and the Way Forward. Curr Atheroscler Rep. 2024 Nov; 26(11):659-671.
Score: 0.026
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference. Curr Atheroscler Rep. 2024 Aug; 26(8):367-381.
Score: 0.025
-
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. Eur J Prev Cardiol. 2024 Mar 27; 31(5):e33-e35.
Score: 0.025
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2024 04; 26(4):119-131.
Score: 0.025
-
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270.
Score: 0.025
-
A review of top cardiology and cardiovascular medicine journal guidelines regarding the use of generative artificial intelligence tools in scientific writing. Curr Probl Cardiol. 2024 Mar; 49(3):102387.
Score: 0.025
-
Cardiovascular disease burden in the Middle East and North Africa region. Curr Probl Cardiol. 2024 Mar; 49(3):102341.
Score: 0.025
-
Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020. JAMA Cardiol. 2023 12 01; 8(12):1185-1187.
Score: 0.024
-
Global Cardiovascular Research: Gaps and Opportunities. Curr Cardiol Rep. 2023 12; 25(12):1831-1838.
Score: 0.024
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress. Curr Atheroscler Rep. 2023 12; 25(12):965-978.
Score: 0.024
-
The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011-22. Eur J Prev Cardiol. 2023 09 20; 30(13):1325-1332.
Score: 0.024
-
Lipoprotein(a) in clinical practice: A guide for the clinician. Prog Cardiovasc Dis. 2023 Jul-Aug; 79:28-36.
Score: 0.024
-
The Association Between Race, Ethnicity and Sleep Quality and Duration: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Dec; 48(12):102004.
Score: 0.024
-
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 08 29; 148(9):e9-e119.
Score: 0.024
-
The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials. Cardiovasc Drugs Ther. 2024 Dec; 38(6):1415-1420.
Score: 0.024
-
The Pandemic of Coronary Heart Disease in South Asia: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 07; 25(7):359-372.
Score: 0.024
-
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
Score: 0.024
-
Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019. Am J Med. 2023 07; 136(7):659-668.e7.
Score: 0.024
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference. Curr Atheroscler Rep. 2023 06; 25(6):309-321.
Score: 0.023
-
Factors Associated With Sex Disparities in Leisure-Time Physical Activity: An Analysis of the Behavioral Risk Factor Surveillance System, 2011 to 2021. Mayo Clin Proc. 2023 07; 98(7):997-1008.
Score: 0.023
-
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? Curr Cardiol Rep. 2023 05; 25(5):423-430.
Score: 0.023
-
Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease. Circulation. 2023 05 02; 147(18):1411-1413.
Score: 0.023
-
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2023 Mar-Apr; 17(2):208-218.
Score: 0.023
-
What is really new in triglyceride guidelines? Curr Opin Endocrinol Diabetes Obes. 2023 04 01; 30(2):73-80.
Score: 0.023
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2023 01; 25(1):31-41.
Score: 0.023
-
Gender Differences in Clinical Outcomes After Percutaneous Coronary Intervention-Analysis of 15,106 Patients from the Cardiac Registry of Pakistan Database. Am J Cardiol. 2023 02 01; 188:61-67.
Score: 0.023
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress. Curr Atheroscler Rep. 2022 12; 24(12):981-993.
Score: 0.023
-
The Fibrates Story - A Tepid End to a PROMINENT Drug. N Engl J Med. 2022 11 24; 387(21):1991-1992.
Score: 0.023
-
Lipid lowering therapy in 2022 and beyond - How far we have come. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:1-3.
Score: 0.023
-
2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 01 24; 81(3):292-317.
Score: 0.023
-
South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent? Prog Cardiovasc Dis. 2022 Nov-Dec; 75:21-32.
Score: 0.023
-
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). Am J Cardiol. 2022 12 01; 184:7-13.
Score: 0.023
-
Racial Disparity in Flu Vaccine Uptake Among Asian American Individuals: A National Health Interview Survey Study. Curr Probl Cardiol. 2022 Dec; 47(12):101391.
Score: 0.022
-
Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019. Circ Heart Fail. 2022 09; 15(9):e009292.
Score: 0.022
-
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:78-82.
Score: 0.022
-
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Prog Cardiovasc Dis. 2022 Sep-Oct; 74:19-27.
Score: 0.022
-
Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already? JAMA Netw Open. 2022 08 01; 5(8):e2228538.
Score: 0.022
-
Association Between Social Vulnerability Index and Cardiovascular Disease: A?Behavioral Risk Factor Surveillance System Study. J Am Heart Assoc. 2022 08 02; 11(15):e024414.
Score: 0.022
-
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance. Vasc Health Risk Manag. 2022; 18:555-566.
Score: 0.022
-
Persistent Racial/Ethnic Disparities in Cardiology Trainees in the United States. J Am Coll Cardiol. 2022 07 19; 80(3):276-279.
Score: 0.022
-
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? Curr Atheroscler Rep. 2022 08; 24(8):627-634.
Score: 0.022
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Curr Atheroscler Rep. 2022 08; 24(8):671-680.
Score: 0.022
-
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey. Am Heart J. 2022 10; 252:60-69.
Score: 0.022
-
Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020. Am J Cardiol. 2022 07 15; 175:184-185.
Score: 0.022
-
Guideline-Concordant Statin Therapy Use?in Secondary Prevention: Should the Medical Community Wait for Divine Intervention? J Am Coll Cardiol. 2022 05 10; 79(18):1814-1817.
Score: 0.022
-
Use of Preventive Cardiovascular Health Care Among Asian American Individuals: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Aug; 48(8):101241.
Score: 0.022
-
Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 05; 349:42-52.
Score: 0.022
-
State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey. Am J Prev Med. 2022 09; 63(3):403-409.
Score: 0.022
-
Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75). Am J Cardiol. 2022 06 15; 173:25-32.
Score: 0.022
-
Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database. Curr Probl Cardiol. 2023 Aug; 48(8):101202.
Score: 0.022
-
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 06; 24(6):689-698.
Score: 0.022
-
Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. Eur J Prev Cardiol. 2022 Mar 25; 29(3):493-501.
Score: 0.022
-
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
Score: 0.022
-
Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2022 Mar 01; 7(3):341-345.
Score: 0.022
-
Age-Related Disparity Trends in Stroke-Related Mortality in the United States, 1999 to 2019. Am J Cardiol. 2022 04 15; 169:162-163.
Score: 0.022
-
Prevalence and Predictors of Premature Coronary Heart Disease Among Asians in the United States: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Jul; 48(7):101152.
Score: 0.022
-
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. Prog Cardiovasc Dis. 2022 Mar-Apr; 71:86-91.
Score: 0.022
-
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 03; 15(3):e007979.
Score: 0.022
-
Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2022 01; 24(1):61-72.
Score: 0.022
-
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:32-40.
Score: 0.022
-
The Utility of Coronary Artery Calcium for Guiding Treatment With Preventive Pharmacotherapy: Opportunities and Nuances. JACC Cardiovasc Imaging. 2022 04; 15(4):652-654.
Score: 0.021
-
Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. Curr Probl Cardiol. 2023 Apr; 48(4):101105.
Score: 0.021
-
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.
Score: 0.021
-
Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 01 25; 145(4):259-267.
Score: 0.021
-
Pragmatic Clinical Trials-Ready for Prime Time? JAMA Netw Open. 2021 12 01; 4(12):e2140212.
Score: 0.021
-
Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey). Am J Cardiol. 2022 02 01; 164:143-145.
Score: 0.021
-
Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy. Curr Probl Cardiol. 2022 Jul; 47(7):101043.
Score: 0.021
-
Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Curr Atheroscler Rep. 2021 10 14; 23(12):76.
Score: 0.021
-
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839.
Score: 0.021
-
Social vulnerability and COVID-19: An analysis of CDC data. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:91-93.
Score: 0.021
-
A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
Score: 0.021
-
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better. Mayo Clin Proc. 2021 10; 96(10):2660-2670.
Score: 0.021
-
Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. Prev Med. 2021 12; 153:106779.
Score: 0.021
-
Epidemiology and risk factors for stroke in young individuals: implications for prevention. Curr Opin Cardiol. 2021 09 01; 36(5):565-571.
Score: 0.021
-
Association Between Cinnamon Consumption and Risk of Cardiovascular Health: A Systematic Review and Meta-Analysis. Am J Med. 2022 01; 135(1):110-117.
Score: 0.021
-
Letter to the Editor: Temporal Changes in Cost-Related Medication Nonadherence by Race/Ethnicity and Medicaid Expansion: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):141-142.
Score: 0.021
-
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.
Score: 0.021
-
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 08 31; 78(9):960-993.
Score: 0.021
-
Promise and Perils of Telehealth in the Current Era. Curr Cardiol Rep. 2021 07 16; 23(9):115.
Score: 0.021
-
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey. Prev Med. 2021 12; 153:106715.
Score: 0.021
-
Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. Adults. Am J Prev Med. 2021 10; 61(4):492-500.
Score: 0.021
-
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2021 07 01; 6(7):782-790.
Score: 0.021
-
Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021 08; 111(8):1518-1522.
Score: 0.021
-
Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). Am J Cardiol. 2021 08 15; 153:142-144.
Score: 0.021
-
Lipoprotein (a): Recent Updates on a Unique Lipoprotein. Curr Atheroscler Rep. 2021 06 19; 23(8):41.
Score: 0.021
-
Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):39-45.
Score: 0.021
-
Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am J Cardiol. 2021 08 01; 152:177-178.
Score: 0.021
-
Health care costs associated with primary care physicians versus nurse practitioners and physician assistants. J Am Assoc Nurse Pract. 2021 05 31; 33(11):967-974.
Score: 0.021
-
Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry. Am Heart J. 2021 10; 240:58-62.
Score: 0.021
-
Has the 'strength' of fish oil therapy been 'reduced'? Reconciling the results of REDUCE-IT and STRENGTH. Eur Heart J Cardiovasc Pharmacother. 2021 05 23; 7(3):e7-e8.
Score: 0.021
-
Statins in COVID-19 infection: A rehash of old themes or truly a new hope? J Clin Lipidol. 2021 May-Jun; 15(3):399-401.
Score: 0.020
-
Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. Am J Med. 2021 08; 134(8):1047-1051.e2.
Score: 0.020
-
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug; 21(4):559-570.
Score: 0.020
-
Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 04; 107(8):650-656.
Score: 0.020
-
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:108-110.
Score: 0.020
-
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther. 2022 04; 36(2):295-300.
Score: 0.020
-
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 02 23; 143(8):e254-e743.
Score: 0.020
-
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 2022 02; 36(1):93-102.
Score: 0.020
-
Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR? PINNACLE Registry. Int J Cardiol. 2021 04 15; 329:209-216.
Score: 0.020
-
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention. Curr Atheroscler Rep. 2021 01 03; 23(1):4.
Score: 0.020
-
Pathophysiological Mechanisms Underlying Excess Risk for Diabetes and Cardiovascular Disease in South Asians: The Perfect Storm. Curr Diabetes Rev. 2021; 17(9):e070320183447.
Score: 0.020
-
State-Level Temporal Trends in Smokeless Tobacco and Cigarette Use Among U.S. Adults. Am J Cardiol. 2021 03 01; 142:145-147.
Score: 0.020
-
Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2021 01; 317:16-21.
Score: 0.020
-
A way to track governments' response and people's mobility changes in response to COVID-19 pandemic. J Glob Health. 2020 Dec; 10(2):020345.
Score: 0.020
-
Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020 Nov-Dec; 14(6):2219-2230.
Score: 0.020
-
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects. J Am Heart Assoc. 2020 11 17; 9(22):e017915.
Score: 0.020
-
Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB? Eur Heart J. 2020 10 21; 41(40):3910-3912.
Score: 0.020
-
Temporal Trends in the Prevalence of Current E-Cigarette and Cigarette Use by Annual Household Income from 2016 to 2018 (from the Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am J Cardiol. 2020 12 15; 137:139-140.
Score: 0.020
-
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep. 2020 10 03; 22(12):72.
Score: 0.020
-
The Reply. Am J Med. 2020 10; 133(10):e608.
Score: 0.020
-
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective. Cardiovasc Drugs Ther. 2021 12; 35(6):1269-1279.
Score: 0.020
-
Letter to the Editor: Temporal Trends in E-Cigarette and Cigarette Use Among US Adults by US State: Behavioral Risk Factor Surveillance System, 2016 to 2018. Popul Health Manag. 2021 06; 24(3):414-415.
Score: 0.020
-
Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts. Indian Heart J. 2020 Sep - Oct; 72(5):337-344.
Score: 0.020
-
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
Score: 0.020
-
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
Score: 0.020
-
Association of Internet Use With the Use of Addictive Substances in the United States. Am J Cardiol. 2020 11 15; 135:182-183.
Score: 0.020
-
Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2020 11 01; 134:146-147.
Score: 0.019
-
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Netw Open. 2020 08 03; 3(8):e2011051.
Score: 0.019
-
Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Curr Atheroscler Rep. 2020 07 16; 22(9):44.
Score: 0.019
-
Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2021 Aug; 46:204-211.
Score: 0.019
-
Association of Smokeless Tobacco Use With the Use of Other Illicit Drugs in the United States. Am J Med. 2021 01; 134(1):e15-e19.
Score: 0.019
-
Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. Am J Med. 2020 12; 133(12):1424-1432.e1.
Score: 0.019
-
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2020 06 18; 22(8):32.
Score: 0.019
-
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions. Curr Atheroscler Rep. 2020 06 03; 22(7):25.
Score: 0.019
-
Surfing the Waves of the COVID-19 Pandemic as a Cardiovascular Clinician. Circulation. 2020 07 14; 142(2):98-100.
Score: 0.019
-
Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit? J Med Econ. 2020 Jul; 23(7):670-672.
Score: 0.019
-
Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia. Circulation. 2020 04 07; 141(14):1121-1123.
Score: 0.019
-
The Way to a Woman's Heart: Assessing, Personalizing, and Reclassifying Atherosclerotic Cardiovascular Disease Risk in Female Patients. Tex Heart Inst J. 2020 04 01; 47(2):125-127.
Score: 0.019
-
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. Am J Med. 2020 09; 133(9):e508-e511.
Score: 0.019
-
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 02 18; 141(7):592-599.
Score: 0.019
-
High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc. 2020 02 04; 9(3):e013600.
Score: 0.019
-
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 03 03; 141(9):e139-e596.
Score: 0.019
-
Improving adherence to cardiovascular guidelines: realistic transition from paper to patient. Expert Rev Cardiovasc Ther. 2020 Jan; 18(1):41-51.
Score: 0.019
-
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2020 01 11; 22(1):3.
Score: 0.019
-
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag. 2020; 16:1-10.
Score: 0.019
-
Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2020 03 15; 125(6):835-839.
Score: 0.019
-
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879.
Score: 0.019
-
Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system. Am Heart J. 2020 03; 221:9-18.
Score: 0.019
-
Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress. Curr Atheroscler Rep. 2019 11 19; 21(12):46.
Score: 0.019
-
Popular Media and Cardiovascular Medicine: "with Great Power There Must Also Come Great Responsibility". Curr Atheroscler Rep. 2019 10 31; 21(11):43.
Score: 0.018
-
Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside. Prog Cardiovasc Dis. 2019 Sep - Oct; 62(5):406-413.
Score: 0.018
-
Therapeutic Inertia in Cardiovascular?Disease Prevention: Time to Move the Bar. J Am Coll Cardiol. 2019 10 01; 74(13):1728-1731.
Score: 0.018
-
Cholesterol Insights and Controversies From the UK Biobank Study. Circulation. 2019 08 13; 140(7):553-555.
Score: 0.018
-
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. J Clin Lipidol. 2019 Sep - Oct; 13(5):797-803.e1.
Score: 0.018
-
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714.
Score: 0.018
-
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). Am J Cardiol. 2019 10 15; 124(8):1165-1170.
Score: 0.018
-
PCSK9 Inhibitors Prior Authorization. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005910.
Score: 0.018
-
Mortality reduction with PCSK9 inhibition: A?case of cautious optimism. J Clin Lipidol. 2019 Sep - Oct; 13(5):712-713.
Score: 0.018
-
Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry. J Am Heart Assoc. 2019 07 02; 8(13):e011412.
Score: 0.018
-
Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2019 05 24; 21(8):31.
Score: 0.018
-
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. Am J Med. 2019 09; 132(9):e693-e700.
Score: 0.018
-
Cardio-metabolic disease risk factors among South Asian labour migrants to the Middle East: a scoping review and policy analysis. Global Health. 2019 05 02; 15(1):33.
Score: 0.018
-
Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1292-1293.
Score: 0.018
-
Childhood Oral Infections and Subclinical Atherosclerosis in Adulthood: Should We Wait for Causality or Just Treat? JAMA Netw Open. 2019 04 05; 2(4):e192489.
Score: 0.018
-
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? J Am Heart Assoc. 2019 04 02; 8(7):e012352.
Score: 0.018
-
The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know. Curr Atheroscler Rep. 2019 04 02; 21(6):20.
Score: 0.018
-
2018 Cholesterol Guidelines: Key Topics in Primary Prevention. Curr Atheroscler Rep. 2019 03 16; 21(5):17.
Score: 0.018
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.018
-
The potential of m-Health-based interventions to improve medication literacy and adherence in non-communicable diseases in Pakistan. Int J Stroke. 2019 04; 14(3):NP8-NP10.
Score: 0.017
-
Socio-economic inequalities in hypertension burden and cascade of services: nationwide cross-sectional study in Nepal. J Hum Hypertens. 2019 08; 33(8):613-625.
Score: 0.017
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.017
-
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials. Curr Atheroscler Rep. 2019 01 10; 21(1):1.
Score: 0.017
-
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.017
-
Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS One. 2018; 13(12):e0197671.
Score: 0.017
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.017
-
Low-Density Lipoprotein Cholesterol: Is 160 the New 190? Circulation. 2018 11 20; 138(21):2326-2329.
Score: 0.017
-
Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options. Tex Heart Inst J. 2018 08; 45(4):238-239.
Score: 0.017
-
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45.
Score: 0.017
-
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004652.
Score: 0.017
-
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey. J Am Heart Assoc. 2018 04 23; 7(9).
Score: 0.017
-
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240.
Score: 0.017
-
Electronic health records and outpatient cardiovascular disease care delivery: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Indian Heart J. 2018 Sep - Oct; 70(5):750-752.
Score: 0.016
-
Premature Coronary Heart Disease in South Asians: Burden and Determinants. Curr Atheroscler Rep. 2018 01 27; 20(1):6.
Score: 0.016
-
Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein. Front Biosci (Landmark Ed). 2018 01 01; 23(6):1099-1112.
Score: 0.016
-
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017 Dec 15; 6(12).
Score: 0.016
-
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
Score: 0.016
-
Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clin Cardiol. 2017 Nov; 40(11):1055-1060.
Score: 0.016
-
Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk. J Am Heart Assoc. 2017 07 14; 6(7).
Score: 0.016
-
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel?Survey. J Am Heart Assoc. 2017 Jun 09; 6(6).
Score: 0.016
-
Overview of Coronary Heart Disease Risk Initiatives in South Asia. Curr Atheroscler Rep. 2017 Jun; 19(6):25.
Score: 0.016
-
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
Score: 0.016
-
Using Mobile Health (mHealth) Technology in the Management of Diabetes Mellitus, Physical Inactivity, and Smoking. Curr Atheroscler Rep. 2017 Apr; 19(4):16.
Score: 0.015
-
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 04 01; 2(4):361-369.
Score: 0.015
-
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential. Curr Atheroscler Rep. 2017 Mar; 19(3):12.
Score: 0.015
-
From Plaque Burden to Plaque Composition: Toward?Personalized Risk?Assessment. JACC Cardiovasc Imaging. 2017 03; 10(3):250-252.
Score: 0.015
-
Evaluating Periodontal Treatment to Prevent Cardiovascular Disease: Challenges and Possible Solutions. Curr Atheroscler Rep. 2017 Jan; 19(1):4.
Score: 0.015
-
Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding. Evid Based Med. 2016 12; 21(6):225.
Score: 0.015
-
Practice-Level Variation in?Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry. J Am Coll Cardiol. 2016 09 20; 68(12):1368-9.
Score: 0.015
-
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. Am J Cardiol. 2016 Sep 15; 118(6 Suppl):13A-8A.
Score: 0.015
-
Economic Impact of Moderate-Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel?Survey. J Am Heart Assoc. 2016 09 07; 5(9).
Score: 0.015
-
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. Am Heart J. 2016 Nov; 181:74-82.
Score: 0.015
-
Cholesterol Guidelines: More Similar Than Different. Prog Cardiovasc Dis. 2016 Sep - Oct; 59(2):190-199.
Score: 0.015
-
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Tex Heart Inst J. 2016 Aug; 43(4):313-4.
Score: 0.015
-
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.015
-
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91.
Score: 0.014
-
Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial. Trials. 2016 Mar 05; 17(1):121.
Score: 0.014
-
Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
Score: 0.014
-
The Role of Ezetimibe in the Treatment of Cardiovascular Disease. Curr Atheroscler Rep. 2016 Feb; 18(2):8.
Score: 0.014
-
Contemporary data on cardiovascular diseases in Indians: American College of Cardiology's PINNACLE India Quality Improvement Program. Indian Heart J. 2016 May-Jun; 68(3):434-5.
Score: 0.014
-
Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20.
Score: 0.014
-
Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity. Curr Atheroscler Rep. 2016 Jan; 18(1):4.
Score: 0.014
-
Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016 May-Jun; 10(3):497-504.e4.
Score: 0.014
-
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812.
Score: 0.014
-
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6.
Score: 0.014
-
Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights From the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). J Am Heart Assoc. 2015 May 20; 4(5).
Score: 0.014
-
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
Score: 0.013
-
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
Score: 0.013
-
Case report: a lead you can't miss: a case of right ventricular perforation. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):51-2.
Score: 0.013
-
Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):53-8.
Score: 0.013
-
Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol. 2014 Dec 09; 64(22):2434-5.
Score: 0.013
-
Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014 Nov; 37(11):653-9.
Score: 0.013
-
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6.
Score: 0.013
-
Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players. South Med J. 2014 Oct; 107(10):633-9.
Score: 0.013
-
Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
Score: 0.013
-
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct; 236(2):251-6.
Score: 0.013
-
What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults? Tex Heart Inst J. 2014 Jun; 41(3):304-5.
Score: 0.013
-
Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7.
Score: 0.013
-
Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014 Jul; 37(7):402-7.
Score: 0.012
-
Decrease the incentives to order lipid panels--reply. JAMA Intern Med. 2014 Mar; 174(3):473-4.
Score: 0.012
-
Novel therapies for treating familial hypercholesterolemia. Curr Atheroscler Rep. 2014 Jan; 16(1):382.
Score: 0.012
-
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther. 2013 Oct; 31(5):291-7.
Score: 0.012
-
Correlates of repeat lipid testing in patients with coronary heart disease. JAMA Intern Med. 2013 Aug 12; 173(15):1439-44.
Score: 0.012
-
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92.
Score: 0.012
-
Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013 Aug 01; 112(3):309-17.
Score: 0.012
-
Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Tex Heart Inst J. 2013; 40(3):288-9.
Score: 0.011
-
Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20.
Score: 0.011
-
Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23.
Score: 0.011
-
Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. J Clin Lipidol. 2012 Nov-Dec; 6(6):545-52.
Score: 0.011
-
Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6.
Score: 0.011
-
Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6.
Score: 0.011
-
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol. 2013 Jul 15; 167(1):180-4.
Score: 0.011
-
Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions. Tex Heart Inst J. 2012; 39(2):228-30.
Score: 0.011
-
Update on therapies targeting HDL: the mystery continues. Curr Opin Lipidol. 2011 Dec; 22(6):514-6.
Score: 0.011
-
Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012 Jan 17; 125(2):241-9.
Score: 0.011
-
Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. J Clin Lipidol. 2012 Jan-Feb; 6(1):50-7.
Score: 0.011
-
Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2.
Score: 0.010
-
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J. 2011 Oct; 162(4):725-732.e1.
Score: 0.010
-
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602.
Score: 0.010
-
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. Am Heart J. 2011 Jun; 161(6):1140-6.
Score: 0.010
-
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
Score: 0.010
-
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2011 May 15; 107(10):1504-9.
Score: 0.010
-
Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J. 2011; 38(2):160-2.
Score: 0.010
-
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011 Feb; 32(4):459-68.
Score: 0.010
-
Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6.
Score: 0.009
-
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future. Curr Opin Lipidol. 2010 Apr; 21(2):165-6.
Score: 0.009
-
Images in echocardiography: a freely floating saphenous vein graft. Echocardiography. 2009 Aug; 26(7):868-9.
Score: 0.009
-
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5.
Score: 0.009
-
Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery? Am J Cardiol. 2008 Nov 01; 102(9):1235-9.
Score: 0.008
-
Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep. 2008 Apr; 10(2):164-70.
Score: 0.008
-
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008 Mar; 155(3):541-6.
Score: 0.008
-
How to identify patients with vulnerable plaques. Diabetes Obes Metab. 2008 Sep; 10(10):824-33.
Score: 0.008
-
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep. 2007 Aug; 9(2):97-103.
Score: 0.008
-
Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007; 34(1):76-9.
Score: 0.008
-
Left main coronary artery stenosis: factors predicting cardiac events in patients awaiting coronary surgery. Tex Heart Inst J. 2006; 33(1):23-6.
Score: 0.007
-
Off-pump coronary artery grafting in patients with left main coronary artery disease. J Card Surg. 2005 Nov-Dec; 20(6):537-41.
Score: 0.007
-
Burden of cardiometabolic diseases and depression in a low-income, urban community in Pakistan: a cross-sectional survey. BMC Public Health. 2025 Feb 24; 25(1):757.
Score: 0.007
-
Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
Score: 0.007
-
CDC WONDER: Trends in diabetes mellitus mortality in the United States from 1968 to 2021. Diabetes Res Clin Pract. 2025 Mar; 221:112012.
Score: 0.007
-
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
Score: 0.007
-
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease. Lancet Gastroenterol Hepatol. 2025 Jan; 10(1):82-94.
Score: 0.007
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
Score: 0.007
-
The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.
Score: 0.007
-
Bayesian Model Projecting Cardiovascular Disease Related Mortality Trends in the United States. J Am Heart Assoc. 2024 Nov 05; 13(21):e035922.
Score: 0.007
-
Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
Score: 0.006
-
A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines. Am J Med. 2025 Feb; 138(2):204-208.
Score: 0.006
-
Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart Study. Vasc Med. 2024 12; 29(6):632-639.
Score: 0.006
-
Health Data Sciences and Cardiovascular Diseases in South Asia: Innovations and Challenges in Digital Health. Curr Atheroscler Rep. 2024 Nov; 26(11):639-648.
Score: 0.006
-
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol. 2024 Sep-Oct; 18(5):e647-e663.
Score: 0.006
-
Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey. Ann Intern Med. 2024 Oct; 177(10):1444-1448.
Score: 0.006
-
Ongoing and future clinical trials of device therapies for patients with heart failure. Curr Probl Cardiol. 2024 Nov; 49(11):102805.
Score: 0.006
-
Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2024 Aug; 17(8):e011199.
Score: 0.006
-
Relationship between race, income-level, and Cardiovascular Disease. J Natl Med Assoc. 2024 Oct; 116(5):539-552.
Score: 0.006
-
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 01; 9(8):741-747.
Score: 0.006
-
Interaction between risk factors, coronary calcium, and CCTA plaque characteristics in patients aged 18-45 years. Eur Heart J Cardiovasc Imaging. 2024 Jul 31; 25(8):1071-1082.
Score: 0.006
-
Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze? Curr Cardiol Rep. 2024 Oct; 26(10):1135-1143.
Score: 0.006
-
Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Jul 23; 31(9):1123-1131.
Score: 0.006
-
Association between a diagnosis of diabetes mellitus and smoking abstinence: An analysis of the National Health Interview Survey (2006-2018). Prev Med. 2024 Oct; 187:108085.
Score: 0.006
-
Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021. BMC Cardiovasc Disord. 2024 07 19; 24(1):378.
Score: 0.006
-
Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study. Circulation. 2024 Jul 16; 150(3):250-252.
Score: 0.006
-
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure. Am J Cardiovasc Drugs. 2024 Jul; 24(4):481-504.
Score: 0.006
-
The Role of Sleep in Cardiovascular Disease. Curr Atheroscler Rep. 2024 Jul; 26(7):249-262.
Score: 0.006
-
Association of High-Density Lipoprotein Parameters and Risk of Heart?Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul; 12(7):1242-1253.
Score: 0.006
-
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population. Curr Atheroscler Rep. 2024 Jul; 26(7):231-248.
Score: 0.006
-
What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
Score: 0.006
-
Cardiovascular Health and Disease in the Pakistani American Population. Curr Atheroscler Rep. 2024 06; 26(6):205-215.
Score: 0.006
-
Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112.
Score: 0.006
-
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer. Tex Heart Inst J. 2024 Apr 09; 51(1).
Score: 0.006
-
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024 May 07; 83(18):1824-1826.
Score: 0.006
-
Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study. Diabetes Care. 2024 Apr 01; 47(4):698-706.
Score: 0.006
-
Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2024 05; 392:117522.
Score: 0.006
-
Association of cardiometabolic and vascular atherosclerosis phenotypes on non-contrast chest CT with incident heart failure in patients with severe hypercholesterolemia. J Clin Lipidol. 2024 May-Jun; 18(3):e403-e412.
Score: 0.006
-
Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study. BMC Cardiovasc Disord. 2024 02 06; 24(1):91.
Score: 0.006
-
Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study. Cardiorenal Med. 2024; 14(1):34-44.
Score: 0.006
-
Oral Health and Cardiovascular Disease. Am J Med. 2024 04; 137(4):304-307.
Score: 0.006
-
Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019. Curr Probl Cardiol. 2024 Feb; 49(2):102342.
Score: 0.006
-
County-Level Cardiologist Density and Mortality in the United States. J Am Heart Assoc. 2023 12 05; 12(23):e031686.
Score: 0.006
-
Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort. Circulation. 2024 02 06; 149(6):417-426.
Score: 0.006
-
Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 02 06; 149(6):430-449.
Score: 0.006
-
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 12 12; 148(24):1982-2004.
Score: 0.006
-
Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: findings from nationally representative data. Eur J Prev Cardiol. 2023 11 09; 30(16):e74-e77.
Score: 0.006
-
Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740.
Score: 0.006
-
Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 11 07; 12(21):e031160.
Score: 0.006
-
Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia. Prog Cardiovasc Dis. 2023 Nov-Dec; 81:105-108.
Score: 0.006
-
Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States. Future Cardiol. 2023 09; 19(12):593-604.
Score: 0.006
-
Strengthening evidence to inform health systems: opportunities for the WHO and partners to accelerate progress on non-communicable diseases. BMJ Glob Health. 2023 11; 8(11).
Score: 0.006
-
Applying the ABCs of Cardiovascular Disease Prevention to the 2023 AHA/ACC Multisociety Chronic Coronary Disease Guidelines. Am J Med. 2024 02; 137(2):85-91.
Score: 0.006
-
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023 11 14; 148(20):1636-1664.
Score: 0.006
-
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023 11 14; 148(20):1606-1635.
Score: 0.006
-
Implementation and Evaluation of a mHealth-Based Community Health Worker Feedback Loop for Hispanics with and at Risk for Diabetes. J Gen Intern Med. 2024 Feb; 39(2):229-238.
Score: 0.006
-
Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War Veterans. J Am Heart Assoc. 2023 10 03; 12(19):e029575.
Score: 0.006
-
Health data ecosystem in Pakistan: a multisectoral qualitative assessment of needs and opportunities. BMJ Open. 2023 09 21; 13(9):e071616.
Score: 0.006
-
Interplay Between Zero CAC, Quantitative Plaque Analysis, and Adverse Events in a Diverse Patient Cohort. Circ Cardiovasc Imaging. 2023 08; 16(8):e015236.
Score: 0.006
-
Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301.
Score: 0.006
-
Trends and Outcomes of Transcatheter Aortic Valve Implantation in Aortic Insufficiency: A Nationwide Readmission Database Analysis. Curr Probl Cardiol. 2024 Jan; 49(1 Pt A):102012.
Score: 0.006
-
The COVID-19 Pandemic and Coronary Heart Disease: the Next Surge. Curr Atheroscler Rep. 2023 09; 25(9):559-569.
Score: 0.006
-
Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients. Prog Cardiovasc Dis. 2023 Jul-Aug; 79:19-27.
Score: 0.006
-
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482.
Score: 0.006
-
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic?Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 08 29; 82(9):833-955.
Score: 0.006
-
Association of Hospital Procedural Volume With Outcomes of Left Ventricular Assist Device Placement. J Card Fail. 2023 11; 29(11):1531-1538.
Score: 0.006
-
Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018). Am J Cardiol. 2023 09 01; 202:41-49.
Score: 0.006
-
Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases. JAMA Netw Open. 2023 07 03; 6(7):e2322727.
Score: 0.006
-
Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease. Am J Med. 2023 12; 136(12):1147-1159.
Score: 0.006
-
Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 06 26; 16(12):1517-1528.
Score: 0.006
-
Integrative Genetic Approach Facilitates Precision Strategies for Acute Myocardial Infarction. Genes (Basel). 2023 06 26; 14(7).
Score: 0.006
-
Celiac Disease and the Risk of Cardiovascular Diseases. Int J Mol Sci. 2023 Jun 09; 24(12).
Score: 0.006
-
Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2024 02; 167(2):723-730.e4.
Score: 0.006
-
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Am J Nephrol. 2023; 54(3-4):126-135.
Score: 0.006
-
Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 2023 05 16; 23(1):900.
Score: 0.006
-
Predictors of Non-Obstructive Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography. Glob Heart. 2023; 18(1):26.
Score: 0.006
-
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023 06; 374:107-120.
Score: 0.006
-
Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort. Lancet Public Health. 2023 05; 8(5):e329-e338.
Score: 0.006
-
Number of Live Births, Age at the Time of Having a Child, Span of Births and Risk of Dementia: A Population-Based Cohort Study of 253,611?U.K. Women. J Womens Health (Larchmt). 2023 06; 32(6):680-692.
Score: 0.006
-
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
Score: 0.006
-
Does Coronary Plaque Morphology Matter Beyond Plaque Burden? Curr Atheroscler Rep. 2023 04; 25(4):167-180.
Score: 0.006
-
Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.
Score: 0.006
-
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 02 21; 147(8):e93-e621.
Score: 0.006
-
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. Am J Kidney Dis. 2023 07; 82(1):53-62.e1.
Score: 0.006
-
Characteristics and outcomes in acute myocardial infarction hospitalizations among the older population (age =80 years) in the United States, 2004-2018. Arch Gerontol Geriatr. 2023 08; 111:104930.
Score: 0.006
-
The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis. Curr Probl Cardiol. 2023 May; 48(5):101593.
Score: 0.006
-
Family income and cardiovascular disease risk in American adults. Sci Rep. 2023 01 06; 13(1):279.
Score: 0.006
-
Graves' disease and pulmonary hypertension: report of 2 cases. Tex Heart Inst J. 2003; 30(4):314-5.
Score: 0.006
-
Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning. Am J Cardiol. 2023 03 01; 190:75-81.
Score: 0.006
-
Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis. Prog Cardiovasc Dis. 2023 Jan-Feb; 76:25-30.
Score: 0.006
-
Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis. Curr Probl Cardiol. 2023 Apr; 48(4):101547.
Score: 0.006
-
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure. Methodist Debakey Cardiovasc J. 2022; 18(5):40-53.
Score: 0.006
-
Association of pessimism with cardiovascular events and all-cause mortality. Prog Cardiovasc Dis. 2023 Jan-Feb; 76:91-98.
Score: 0.006
-
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report. Arterioscler Thromb Vasc Biol. 2022 12; 42(12):1461-1467.
Score: 0.006
-
Outcomes of Intravascular Imaging in Orbital Atherectomy; Insight From the National Readmissions Database. Curr Probl Cardiol. 2023 Feb; 48(2):101475.
Score: 0.006
-
Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 11; 11(21):e026762.
Score: 0.006
-
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017-2020. Eur J Prev Cardiol. 2022 10 20; 29(14):1830-1838.
Score: 0.006
-
A stepwise approach to prescribing novel lipid-lowering medications. J Clin Lipidol. 2022 Nov-Dec; 16(6):822-832.
Score: 0.006
-
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022 10 14; 43(39):3925-3946.
Score: 0.006
-
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019. Circ Cardiovasc Qual Outcomes. 2022 12; 15(12):e008861.
Score: 0.006
-
World Heart Federation Cholesterol Roadmap 2022. Glob Heart. 2022; 17(1):75.
Score: 0.006
-
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database. Catheter Cardiovasc Interv. 2022 11; 100(6):1119-1131.
Score: 0.006
-
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Lipidol. 2022 Nov-Dec; 16(6):870-877.
Score: 0.006
-
The Impact of the Affordable Care Act on Disparities in Utilization of Cardiovascular Preventive Services by Socioeconomic Status. Popul Health Manag. 2022 10; 25(5):669-676.
Score: 0.006
-
Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus. Am J Cardiol. 2022 Oct 15; 181:130-138.
Score: 0.006
-
Leveraging Clinical Digitized Data to Understand Temporal Characteristics and Outcomes of Acute Myocardial Infarctions at a Tertiary Care Medical Centre in Pakistan from 1988-2018 - Methods and Results. Glob Heart. 2022; 17(1):58.
Score: 0.006
-
Meta-analysis of Per-Day Step Count and All-Cause Mortality. Am J Cardiol. 2022 10 01; 180:166-168.
Score: 0.006
-
Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention. J Am Heart Assoc. 2022 08 02; 11(15):e026600.
Score: 0.006
-
Revisiting diuretic choice in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):406-413.
Score: 0.006
-
State-Level Social Vulnerability Index and Healthcare Access in Patients With Atherosclerotic Cardiovascular Disease (from the BRFSS Survey). Am J Cardiol. 2022 09 01; 178:149-153.
Score: 0.006
-
Association of dementia with in-hospital outcomes in primary heart failure and acute myocardial infarction hospitalizations. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:24-31.
Score: 0.006
-
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry. J Am Heart Assoc. 2022 06 07; 11(11):e024107.
Score: 0.006
-
Alcohol Consumption and Cardiovascular Health. Am J Med. 2022 10; 135(10):1213-1230.e3.
Score: 0.005
-
Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center. J Clin Lipidol. 2022 Jul-Aug; 16(4):491-497.
Score: 0.005
-
Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants. Biol Sex Differ. 2022 05 07; 13(1):21.
Score: 0.005
-
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121?000 first-generation Asian immigrants. Eur J Prev Cardiol. 2022 05 06; 29(6):916-924.
Score: 0.005
-
Strength training and cardiovascular health: A meta-analysis. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:85-87.
Score: 0.005
-
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89.
Score: 0.005
-
Individual sentiments on telehealth in the COVID-19 era: Insights from Twitter. Prog Cardiovasc Dis. 2022 Mar-Apr; 71:100-102.
Score: 0.005
-
Clinical and Economic Profile of Homeless Young Adults with Stroke in the United States, 2002-2017. Curr Probl Cardiol. 2023 Aug; 48(8):101190.
Score: 0.005
-
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease. Am Heart J. 2022 07; 249:12-22.
Score: 0.005
-
Adherence Clubs to Improve Hypertension Management in Nigeria: Clubmeds, a Feasibility Study. Glob Heart. 2022; 17(1):21.
Score: 0.005
-
Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 04; 15(4):e007908.
Score: 0.005
-
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. J Am Coll Cardiol. 2022 03 01; 79(8):757-768.
Score: 0.005
-
Discordance Between Standard Equations for Determination of LDL?Cholesterol in Patients With?Atherosclerosis. J Am Coll Cardiol. 2022 02 15; 79(6):530-541.
Score: 0.005
-
Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022 02 09; 28(18):2001-2009.
Score: 0.005
-
Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up. J Gen Intern Med. 2022 09; 37(12):3062-3069.
Score: 0.005
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.005
-
Social determinants of health and obesity: Findings from a national study of US adults. Obesity (Silver Spring). 2022 02; 30(2):491-502.
Score: 0.005
-
Social Determinants of Health Among Non-Elderly Adults With Stroke in the United States. Mayo Clin Proc. 2022 02; 97(2):238-249.
Score: 0.005
-
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. Circ Heart Fail. 2022 05; 15(5):e008943.
Score: 0.005
-
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 02 22; 145(8):e153-e639.
Score: 0.005
-
Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019. J Am Heart Assoc. 2022 01 04; 11(1):e021682.
Score: 0.005
-
Temporal Trends in Characteristics and Outcomes Associated With In-Hospital Cardiac Arrest: A 20-Year Analysis (1999-2018). J Am Heart Assoc. 2021 12 07; 10(23):e021572.
Score: 0.005
-
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification. Am J Med. 2022 05; 135(5):603-606.
Score: 0.005
-
Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States, 2004-2018. Curr Probl Cardiol. 2022 Nov; 47(11):101070.
Score: 0.005
-
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285.
Score: 0.005
-
Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians? Curr Cardiol Rep. 2021 10 23; 23(12):181.
Score: 0.005
-
Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018. Circulation. 2021 10 19; 144(16):1272-1279.
Score: 0.005
-
Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis. PLoS One. 2021; 16(10):e0258494.
Score: 0.005
-
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021 10 01; 6(10):1161-1170.
Score: 0.005
-
Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device. Curr Probl Cardiol. 2022 12; 47(12):101009.
Score: 0.005
-
Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899.
Score: 0.005
-
Cigarette smokers' perceptions of smoking cessation and associated factors in Karachi, Pakistan. Public Health Nurs. 2022 03; 39(2):381-389.
Score: 0.005
-
Methodological Rigor and Temporal Trends of Cardiovascular Medicine Meta-Analyses in Highest-Impact Journals. J Am Heart Assoc. 2021 09 21; 10(18):e021367.
Score: 0.005
-
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007485.
Score: 0.005
-
Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018. J Am Heart Assoc. 2021 09 07; 10(17):e021361.
Score: 0.005
-
Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007237.
Score: 0.005
-
Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. J Am Heart Assoc. 2021 08 17; 10(16):e020028.
Score: 0.005
-
Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project. Circ Cardiovasc Interv. 2021 08; 14(8):e010323.
Score: 0.005
-
Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa. 2021 Nov; 50(6):439-445.
Score: 0.005
-
Mentored implementation to initiate a diabetes program in an underserved community: a pilot study. BMJ Open Diabetes Res Care. 2021 08; 9(1).
Score: 0.005
-
Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement. J Am Heart Assoc. 2021 08 03; 10(15):e019671.
Score: 0.005
-
Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Curr Atheroscler Rep. 2021 07 26; 23(9):55.
Score: 0.005
-
Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Curr Cardiol Rep. 2021 07 16; 23(9):116.
Score: 0.005
-
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). J Clin Lipidol. 2021 Sep-Oct; 15(5):649-652.
Score: 0.005
-
Social media and predictive analysis regarding dietary approaches to stop hypertension. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:88-90.
Score: 0.005
-
Stroke-Related Mortality in the United States-Mexico Border Area of the United States, 1999 to 2018. J Am Heart Assoc. 2021 07 06; 10(13):e019993.
Score: 0.005
-
Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1).
Score: 0.005
-
Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2021 Nov; 21(6):659-668.
Score: 0.005
-
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
Score: 0.005
-
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol. Eur Heart J. 2021 06 07; 42(22):2154-2169.
Score: 0.005
-
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800.
Score: 0.005
-
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clin Cardiol. 2021 Jun; 44(6):863-870.
Score: 0.005
-
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiol. 2021 05 01; 6(5):574-580.
Score: 0.005
-
Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA. 2021 Apr 20; 325(15):1545-1555.
Score: 0.005
-
Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):114-121.
Score: 0.005
-
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
Score: 0.005
-
Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovasc Revasc Med. 2022 01; 34:63-68.
Score: 0.005
-
Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis. Expert Rev Cardiovasc Ther. 2021 Mar; 19(3):269-276.
Score: 0.005
-
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21.
Score: 0.005
-
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e006548.
Score: 0.005
-
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
Score: 0.005
-
Fish Consumption and Cardiovascular Health: A Systematic Review. Am J Med. 2021 06; 134(6):713-720.
Score: 0.005
-
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:111-113.
Score: 0.005
-
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA Cardiol. 2021 01 01; 6(1):87-91.
Score: 0.005
-
Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study. JAMA Cardiol. 2021 01 01; 6(1):79-86.
Score: 0.005
-
Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Curr Diabetes Rev. 2021; 17(9):e011221190238.
Score: 0.005
-
Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database). Am J Cardiol. 2021 03 15; 143:97-103.
Score: 0.005
-
Mushroom Consumption and Cardiovascular Health: A Systematic Review. Am J Med. 2021 05; 134(5):637-642.e2.
Score: 0.005
-
Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12).
Score: 0.005
-
Telomere length in young patients with acute myocardial infarction without conventional risk factors: A pilot study from a South Asian population. Indian Heart J. 2020 Nov-Dec; 72(6):619-622.
Score: 0.005
-
Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
Score: 0.005
-
Association Between Sociodemographic Determinants and Disparities in Stroke Symptom Awareness Among US Young Adults. Stroke. 2020 12; 51(12):3552-3561.
Score: 0.005
-
Prescribing Patterns of Antihypertensive Medications in Low- and Middle-Income Countries: A Systematic Review. Asia Pac J Public Health. 2021 01; 33(1):14-22.
Score: 0.005
-
Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA Intern Med. 2020 10 01; 180(10):1317-1327.
Score: 0.005
-
Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015. J Am Heart Assoc. 2020 10 20; 9(19):e016744.
Score: 0.005
-
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol. 2021 05; 31(3):e2172.
Score: 0.005
-
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. J Am Coll Cardiol. 2020 08 18; 76(7):781-793.
Score: 0.005
-
Targeting Inflammation After Myocardial Infarction. Curr Cardiol Rep. 2020 08 08; 22(10):110.
Score: 0.005
-
Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review. Atherosclerosis. 2020 08; 306:22-32.
Score: 0.005
-
Cardiorespiratory Fitness and Incident Stroke Types: The FIT (Henry Ford ExercIse Testing) Project. Mayo Clin Proc. 2020 07; 95(7):1379-1389.
Score: 0.005
-
Meditation and Cardiovascular Health in the US. Am J Cardiol. 2020 09 15; 131:23-26.
Score: 0.005
-
Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis. Circulation. 2020 08 18; 142(7):657-669.
Score: 0.005
-
Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry. J Am Coll Cardiol. 2020 06 02; 75(21):2749-2750.
Score: 0.005
-
Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
Score: 0.005
-
Temporal Trends in Percutaneous Coronary?Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program. J Am Heart Assoc. 2020 06 02; 9(11):e015317.
Score: 0.005
-
Novel emerging therapies in atherosclerosis targeting lipid metabolism. Expert Opin Investig Drugs. 2020 Jun; 29(6):611-622.
Score: 0.005
-
The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis. Atherosclerosis. 2020 07; 304:44-52.
Score: 0.005
-
Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
Score: 0.005
-
Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States. J Am Heart Assoc. 2020 05 18; 9(10):e015523.
Score: 0.005
-
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry. Clin Cardiol. 2020 Jul; 43(7):743-751.
Score: 0.005
-
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry. Am Heart J. 2020 07; 225:88-96.
Score: 0.005
-
Pet Ownership and Cardiovascular Health in the US General Population. Am J Cardiol. 2020 04 15; 125(8):1158-1161.
Score: 0.005
-
Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e006139.
Score: 0.005
-
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
Score: 0.005
-
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 01 07; 75(1):93-112.
Score: 0.005
-
Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med. 2020 08; 21(8):1016-1021.
Score: 0.005
-
Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States. JAMA Netw Open. 2019 12 02; 2(12):e1917885.
Score: 0.005
-
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. Circulation. 2019 12 17; 140(25):2067-2075.
Score: 0.005
-
Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease. JACC Cardiovasc Imaging. 2020 04; 13(4):1090-1092.
Score: 0.005
-
"Zero": The New Superhero or Superhero in Training? J Am Coll Cardiol. 2019 11 05; 74(18):2331.
Score: 0.005
-
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
Score: 0.005
-
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
Score: 0.005
-
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. J Am Heart Assoc. 2019 10; 8(19):e013229.
Score: 0.005
-
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
Score: 0.005
-
Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078.
Score: 0.005
-
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes. Glob Heart. 2019 09; 14(3):215-240.
Score: 0.005
-
Gaps in provider lifestyle counseling and its adherence among obese adults with prediabetes and diabetes in the United States. Prev Med. 2019 12; 129:105815.
Score: 0.005
-
Sex Differences in the Use of Statins in Community Practice. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005562.
Score: 0.005
-
Meta-Analysis of Catheter Directed Ultrasound-Assisted Thrombolysis in Pulmonary Embolism. Am J Cardiol. 2019 11 01; 124(9):1470-1477.
Score: 0.005
-
High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. J Am Geriatr Soc. 2019 11; 67(11):2353-2361.
Score: 0.005
-
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol. 2020 10; 27(15):1597-1605.
Score: 0.005
-
Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Curr Atheroscler Rep. 2019 06 22; 21(9):32.
Score: 0.004
-
The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project). Am J Cardiol. 2019 08 15; 124(4):511-517.
Score: 0.004
-
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2019 08; 214:113-124.
Score: 0.004
-
Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol. JAMA Cardiol. 2019 05 01; 4(5):473-477.
Score: 0.004
-
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology. 2019 05 28; 92(22):e2580-e2593.
Score: 0.004
-
Understanding by General Providers of the Echocardiogram Report. Am J Cardiol. 2019 07 15; 124(2):296-302.
Score: 0.004
-
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. J Am Heart Assoc. 2019 04 02; 8(7):e011765.
Score: 0.004
-
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev. 2019 04 01; 40(2):537-557.
Score: 0.004
-
Subsequent Event Risk in Individuals With Established Coronary Heart Disease. Circ Genom Precis Med. 2019 04; 12(4):e002470.
Score: 0.004
-
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events. Circ Genom Precis Med. 2019 04; 12(4):e002471.
Score: 0.004
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 09 10; 140(11):e563-e595.
Score: 0.004
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 09 10; 140(11):e596-e646.
Score: 0.004
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular?Disease: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 09 10; 74(10):e177-e232.
Score: 0.004
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 09 10; 74(10):1376-1414.
Score: 0.004
-
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 03 05; 139(10):e56-e528.
Score: 0.004
-
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2019 03 01; 4(3):206-213.
Score: 0.004
-
Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2019 02 19; 73(6):727-732.
Score: 0.004
-
Association of Income Disparities with Patient-Reported Healthcare Experience. J Gen Intern Med. 2019 06; 34(6):884-892.
Score: 0.004
-
Combating non-communicable diseases: potentials and challenges for community health workers in a digital age, a narrative review of the literature. Health Policy Plan. 2019 Feb 01; 34(1):55-66.
Score: 0.004
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.004
-
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry). Am J Cardiol. 2019 04 01; 123(7):1011-1018.
Score: 0.004
-
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 03; 282:52-56.
Score: 0.004
-
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences. JAMA Cardiol. 2018 12 01; 3(12):1192-1199.
Score: 0.004
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3168-3209.
Score: 0.004
-
Use of Risk Assessment Tools to?Guide?Decision-Making in the?Primary?Prevention of Atherosclerotic?Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2019 06 25; 73(24):3153-3167.
Score: 0.004
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):e285-e350.
Score: 0.004
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1046-e1081.
Score: 0.004
-
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 06 18; 139(25):e1162-e1177.
Score: 0.004
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1082-e1143.
Score: 0.004
-
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications. Am J Med. 2019 01; 132(1):61-70.e1.
Score: 0.004
-
Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry. J Am Heart Assoc. 2018 09 18; 7(18):e009251.
Score: 0.004
-
Are All Benefits and Harms Equal? J Am Coll Cardiol. 2018 08 14; 72(7):819-820.
Score: 0.004
-
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry. JAMA Cardiol. 2018 08 01; 3(8):739-748.
Score: 0.004
-
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2018 07 10; 72(2):156-169.
Score: 0.004
-
Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure. Appl Clin Inform. 2018 04; 9(2):478-489.
Score: 0.004
-
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Heart Assoc. 2018 06 13; 7(12).
Score: 0.004
-
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
Score: 0.004
-
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System. Am J Cardiol. 2018 09 01; 122(5):756-761.
Score: 0.004
-
Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 08; 275:174-181.
Score: 0.004
-
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse. J Clin Lipidol. 2018 Sep - Oct; 12(5):1141-1145.
Score: 0.004
-
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 05 21; 20(7):35.
Score: 0.004
-
Statin Use and Adverse Effects Among Adults >75?Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. J Am Heart Assoc. 2018 05 08; 7(10).
Score: 0.004
-
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration. J Gen Intern Med. 2018 08; 33(8):1276-1282.
Score: 0.004
-
High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
Score: 0.004
-
Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults. J Am Coll Cardiol. 2018 06 05; 71(22):2527-2536.
Score: 0.004
-
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry. Circ Cardiovasc Qual Outcomes. 2018 03; 11(3):e004249.
Score: 0.004
-
Aberrant Course of Pacemaker Leads: When Left is Left. Tex Heart Inst J. 2018 02; 45(1):52-53.
Score: 0.004
-
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 03 20; 137(12):e67-e492.
Score: 0.004
-
Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia. Indian Heart J. 2018 Sep - Oct; 70(5):721-730.
Score: 0.004
-
National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel?Survey. J Am Heart Assoc. 2018 01 22; 7(2).
Score: 0.004
-
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. Atherosclerosis. 2018 02; 269:301-305.
Score: 0.004
-
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. J Clin Lipidol. 2018 Mar - Apr; 12(2):367-374.e3.
Score: 0.004
-
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol. 2017 12 01; 2(12):1369-1374.
Score: 0.004
-
Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States. Circulation. 2018 01 23; 137(4):408-410.
Score: 0.004
-
Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study. J Clin Lipidol. 2017 Nov - Dec; 11(6):1458-1470.e4.
Score: 0.004
-
Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis. Ir J Med Sci. 2018 May; 187(2):369-377.
Score: 0.004
-
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project. Am Heart J. 2018 01; 195:151-152.
Score: 0.004
-
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854.
Score: 0.004
-
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
Score: 0.004
-
"All hands on deck": An imperative for tackling hypertension in South Asia. Indian Heart J. 2017 Jul - Aug; 69(4):430-431.
Score: 0.004
-
Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Jun 27; 6(6).
Score: 0.004
-
Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project. JAMA Intern Med. 2017 06 01; 177(6):887-889.
Score: 0.004
-
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol. 2017 07; 5(7):534-543.
Score: 0.004
-
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137.
Score: 0.004
-
Understanding Self-regulation Behaviors in South Asians With Coronary Artery Disease: A Mixed-Methods Study. J Cardiovasc Nurs. 2017 May/Jun; 32(3):281-287.
Score: 0.004
-
Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. Circ Cardiovasc Qual Outcomes. 2017 04; 10(4).
Score: 0.004
-
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience. J Clin Lipidol. 2017 May - Jun; 11(3):596-599.
Score: 0.004
-
Factors associated with rhythm control treatment decisions in patients with atrial fibrillation-Insights from the NCDR PINNACLE registry. Am Heart J. 2017 May; 187:88-97.
Score: 0.004
-
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis. 2017 03; 258:79-83.
Score: 0.004
-
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
Score: 0.004
-
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2017 01 01; 2(1):47-54.
Score: 0.004
-
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey. JAMA Cardiol. 2017 01 01; 2(1):56-65.
Score: 0.004
-
Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
Score: 0.004
-
Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
Score: 0.004
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project. Am J Cardiol. 2017 02 15; 119(4):579-584.
Score: 0.004
-
Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. J Eval Clin Pract. 2018 02; 24(1):48-55.
Score: 0.004
-
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 10 06; 5(10).
Score: 0.004
-
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. Am Heart J. 2016 Dec; 182:97-102.
Score: 0.004
-
American College of Cardiology (ACC)'s PINNACLE India Quality Improvement Program (PIQIP)-Inception, progress and future direction: A report from the PIQIP Investigators. Indian Heart J. 2016 Dec; 68 Suppl 3:S1-S4.
Score: 0.004
-
The Role of Intracoronary Plaque Imaging with Intravascular Ultrasound, Optical Coherence Tomography, and Near-Infrared Spectroscopy in Patients with Coronary Artery Disease. Curr Atheroscler Rep. 2016 09; 18(9):57.
Score: 0.004
-
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016 10; 253:156-163.
Score: 0.004
-
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). Am J Cardiol. 2016 Nov 01; 118(9):1399-1404.
Score: 0.004
-
Antiplatelet Management for Coronary Heart Disease: Advances and Challenges. Curr Atheroscler Rep. 2016 Jun; 18(6):35.
Score: 0.004
-
Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines. Obesity (Silver Spring). 2016 07; 24(7):1554-60.
Score: 0.004
-
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A?Critique. Am J Med. 2016 09; 129(9):906-12.
Score: 0.004
-
Gender disparities in cardiovascular care access and delivery in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Int J Cardiol. 2016 Jul 15; 215:248-51.
Score: 0.004
-
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther. 2016 Apr; 30(2):189-98.
Score: 0.004
-
A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US?and Non-US Populations. Mayo Clin Proc. 2016 05; 91(5):649-70.
Score: 0.004
-
Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):143-53.
Score: 0.004
-
The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36.
Score: 0.004
-
Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54.
Score: 0.004
-
Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes. J Dent Res. 2016 Apr; 95(4):408-15.
Score: 0.004
-
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-360.
Score: 0.004
-
Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study). Am J Cardiol. 2016 Mar 01; 117(5):787-93.
Score: 0.004
-
Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. JACC Cardiovasc Imaging. 2016 09; 9(9):1118-1119.
Score: 0.004
-
Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records. Med Care. 2015 Oct; 53(10):901-7.
Score: 0.003
-
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2015 Nov; 170(5):865-71.
Score: 0.003
-
Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region. J Cardiovasc Pharmacol. 2015 Aug; 66(2):183-8.
Score: 0.003
-
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). J Clin Lipidol. 2015 Sep-Oct; 9(5):676-83.
Score: 0.003
-
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015 Sep; 242(1):243-50.
Score: 0.003
-
Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015 Sep; 66(3):474-80.
Score: 0.003
-
Postprandial effects on arterial stiffness parameters in healthy young adults. Vasc Med. 2015 Dec; 20(6):501-8.
Score: 0.003
-
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry). Am J Cardiol. 2015 Aug 15; 116(4):547-53.
Score: 0.003
-
The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia. Curr Atheroscler Rep. 2015 May; 17(5):508.
Score: 0.003
-
Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clin Cardiol. 2015 Apr; 38(4):195-9.
Score: 0.003
-
Revisiting the economic efficiencies of observation units. Manag Care. 2015 Mar; 24(3):46-52.
Score: 0.003
-
Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? J Am Heart Assoc. 2015 Feb 19; 4(2).
Score: 0.003
-
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA Intern Med. 2015 Jan; 175(1):138-40.
Score: 0.003
-
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
Score: 0.003
-
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
Score: 0.003
-
Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Dec 02; 64(21):2183-92.
Score: 0.003
-
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
Score: 0.003
-
One-year outcomes associated with using observation services in triaging patients with nonspecific chest pain. Clin Cardiol. 2014 Oct; 37(10):591-6.
Score: 0.003
-
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):2246-64.
Score: 0.003
-
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 09; 64(22):2406-25.
Score: 0.003
-
Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction. Cardiol Clin. 2014 Aug; 32(3):353-70.
Score: 0.003
-
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. Atherosclerosis. 2014 Jun; 234(2):249-53.
Score: 0.003
-
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
Score: 0.003
-
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1069-77.
Score: 0.003
-
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
Score: 0.003
-
Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2014 Mar 01; 172(1):239-41.
Score: 0.003
-
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):e28-e292.
Score: 0.003
-
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014 Jan 07; 129(1):77-86.
Score: 0.003
-
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec; 231(2):371-7.
Score: 0.003
-
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
Score: 0.003
-
Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43.
Score: 0.003
-
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013 Oct 09; 168(4):3741-6.
Score: 0.003
-
Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? Methodist Debakey Cardiovasc J. 2013 Jul-Sep; 9(3):169-72.
Score: 0.003
-
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr. 2013 Aug; 26(8):901-909.e1.
Score: 0.003
-
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
Score: 0.003
-
Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013 Jul; 44(7):1803-8.
Score: 0.003
-
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy. J Lipid Res. 2013 Jul; 54(7):1980-7.
Score: 0.003
-
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):143-52.
Score: 0.003
-
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
Score: 0.003
-
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
Score: 0.003
-
Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study. Eur J Prev Cardiol. 2014 Jul; 21(7):866-75.
Score: 0.003
-
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. J Clin Lipidol. 2013 Jan-Feb; 7(1):82-7.
Score: 0.003
-
Impact of clinical complexity on the quality of diabetes care. Am J Manag Care. 2012 09; 18(9):508-14.
Score: 0.003
-
Impact of colchicine on pericardial inflammatory syndromes--an analysis of randomized clinical trials. Int J Cardiol. 2012 Nov 01; 161(1):59-62.
Score: 0.003
-
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug; 223(2):421-6.
Score: 0.003
-
Medicare eligibility and physician utilization among adults with coronary heart disease and stroke. Med Care. 2012 Jun; 50(6):547-53.
Score: 0.003
-
ST elevation: telling pathology from the benign patterns. Glob J Health Sci. 2012 Apr 28; 4(3):51-63.
Score: 0.003
-
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
Score: 0.003
-
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May; 222(1):135-7.
Score: 0.003
-
Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc. 2012 Feb; 60(2):193-201.
Score: 0.003
-
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. J Lipid Res. 2012 Mar; 53(3):556-560.
Score: 0.003
-
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
Score: 0.003
-
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
Score: 0.003
-
Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):682-688.e1.
Score: 0.003
-
Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan; 43(1):103-8.
Score: 0.003
-
Segmental analysis of carotid arterial strain using speckle-tracking. J Am Soc Echocardiogr. 2011 Nov; 24(11):1276-1284.e5.
Score: 0.003
-
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Atherosclerosis. 2011 Dec; 219(2):737-42.
Score: 0.003
-
Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magn Reson Imaging. 2011 Oct; 29(8):1065-75.
Score: 0.003
-
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr. 2011 Jul; 24(7):720-8.
Score: 0.003
-
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 05; 123(13):1367-76.
Score: 0.003
-
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. J Vasc Surg. 2011 Mar; 53(3):668-75.
Score: 0.003
-
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15; 54(25):2388-95.
Score: 0.002
-
Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J. 2009; 36(5):494-5.
Score: 0.002
-
Cardiac sarcoidosis: a clinical entity uncommonly recognized. Tex Heart Inst J. 2009; 36(5):501-3.
Score: 0.002
-
Rescue percutaneous coronary intervention for graft failure immediately after coronary artery bypass grafting: case report and review of literature. J Card Surg. 2008 Nov-Dec; 23(6):709-12.
Score: 0.002
-
Lipid management: considerations in acute coronary syndrome. Curr Cardiol Rep. 2008 Jul; 10(4):334-41.
Score: 0.002
-
Contrast echocardiography for right-sided heart conditions: case reports and literature review. Tex Heart Inst J. 2008; 35(1):38-41.
Score: 0.002
-
Cor triatriatum dexter. Tex Heart Inst J. 2007; 34(3):383-5.
Score: 0.002
-
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men. Am J Cardiol. 2005 May 15; 95(10):1258-60.
Score: 0.002
-
Noncardiac surgery following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004 Nov; 63(3):267-73.
Score: 0.002
-
The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. Biochem Pharmacol. 1998 Oct 15; 56(8):955-60.
Score: 0.001
-
The antiplatelet aggregatory activity of Acacia nilotica is due to blockade of calcium influx through membrane calcium channels. Gen Pharmacol. 1997 Aug; 29(2):251-5.
Score: 0.001